Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Johnson and Johnson
Chubb
McKinsey
Cantor Fitzgerald
UBS
Chinese Patent Office
Fuji
Farmers Insurance
Harvard Business School

Generated: February 21, 2018

DrugPatentWatch Database Preview

IMIPENEM AND CILASTATIN Drug Profile

« Back to Dashboard

Which patents cover Imipenem And Cilastatin, and what generic alternatives are available?

Imipenem And Cilastatin is a drug marketed by Acs Dobfar and Hospira Inc and is included in three NDAs.

The generic ingredient in IMIPENEM AND CILASTATIN is cilastatin sodium; imipenem. There are sixteen drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the cilastatin sodium; imipenem profile page.
Summary for IMIPENEM AND CILASTATIN
Drug patent expirations by year for IMIPENEM AND CILASTATIN
Pharmacology for IMIPENEM AND CILASTATIN

US Patents and Regulatory Information for IMIPENEM AND CILASTATIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Acs Dobfar IMIPENEM AND CILASTATIN cilastatin sodium; imipenem POWDER;INTRAVENOUS 090577-001 Dec 21, 2011 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Hospira Inc IMIPENEM AND CILASTATIN cilastatin sodium; imipenem POWDER;INTRAVENOUS 090825-002 Nov 16, 2011 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Acs Dobfar IMIPENEM AND CILASTATIN cilastatin sodium; imipenem POWDER;INTRAVENOUS 090577-002 Dec 21, 2011 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Hospira Inc IMIPENEM AND CILASTATIN cilastatin sodium; imipenem POWDER;INTRAVENOUS 090825-001 Nov 16, 2011 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Hospira Inc IMIPENEM AND CILASTATIN cilastatin sodium; imipenem POWDER;INTRAVENOUS 091007-001 Nov 16, 2011 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
McKesson
Boehringer Ingelheim
Accenture
Teva
Citi
Argus Health
Express Scripts
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot